• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可诱导性蛋白病

Inducible proteopathies.

作者信息

Walker Lary C, Levine Harry, Mattson Mark P, Jucker Mathias

机构信息

Yerkes National Primate Research Center and Department of Neurology, Emory University, Atlanta, GA 30322, USA.

出版信息

Trends Neurosci. 2006 Aug;29(8):438-43. doi: 10.1016/j.tins.2006.06.010. Epub 2006 Jun 27.

DOI:10.1016/j.tins.2006.06.010
PMID:16806508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10725716/
Abstract

Numerous degenerative diseases are characterized by the aberrant polymerization and accumulation of specific proteins. These proteopathies include neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease and the prion diseases, in addition to diverse systemic disorders, particularly the amyloidoses. The prion diseases have been shown to be transmissible by an alternative conformation of the normal cellular prion protein. Other proteopathies have been thought to be non-transmissible, but there is growing evidence that some systemic and cerebral amyloidoses can be induced by exposure of susceptible hosts to cognate molecular templates. As we review here, the mechanistic similarities among these diseases provide unprecedented opportunities for elucidating the induction of protein misfolding and assembly in vivo, and for developing an integrated therapeutic approach to degenerative proteopathies.

摘要

许多退行性疾病的特征是特定蛋白质的异常聚合和积累。这些蛋白质病包括神经疾病,如阿尔茨海默病、帕金森病、亨廷顿病和朊病毒病,此外还有各种全身性疾病,特别是淀粉样变性病。已证明朊病毒病可通过正常细胞朊蛋白的另一种构象进行传播。其他蛋白质病一直被认为是不可传播的,但越来越多的证据表明,一些全身性和脑淀粉样变性病可由易感宿主接触同源分子模板诱发。正如我们在此所综述的,这些疾病之间的机制相似性为阐明体内蛋白质错误折叠和组装的诱导过程,以及开发针对退行性蛋白质病的综合治疗方法提供了前所未有的机会。

相似文献

1
Inducible proteopathies.可诱导性蛋白病
Trends Neurosci. 2006 Aug;29(8):438-43. doi: 10.1016/j.tins.2006.06.010. Epub 2006 Jun 27.
2
The cerebral proteopathies: neurodegenerative disorders of protein conformation and assembly.大脑蛋白病:蛋白质构象和组装的神经退行性疾病。
Mol Neurobiol. 2000 Feb-Apr;21(1-2):83-95. doi: 10.1385/MN:21:1-2:083.
3
[Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].[朊病毒样传播会在神经退行性疾病中发生吗?:鉴于可传播的系统性淀粉样变性]
Brain Nerve. 2012 Jun;64(6):665-74.
4
[Neurodegenerative amyloidoses: the yeast model].[神经退行性淀粉样变性:酵母模型]
Mol Biol (Mosk). 2007 Mar-Apr;41(2):346-54.
5
Neurodegenerative diseases: expanding the prion concept.神经退行性疾病:扩展朊病毒概念
Annu Rev Neurosci. 2015 Jul 8;38:87-103. doi: 10.1146/annurev-neuro-071714-033828. Epub 2015 Mar 30.
6
Application of yeast to studying amyloid and prion diseases.酵母在淀粉样变性和朊病毒病研究中的应用。
Adv Genet. 2020;105:293-380. doi: 10.1016/bs.adgen.2020.01.002. Epub 2020 May 4.
7
Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?朊病毒病:独特的传染性病原体还是神经退行性疾病的模型?
Biomolecules. 2021 Feb 2;11(2):207. doi: 10.3390/biom11020207.
8
Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key?在体内模拟阿尔茨海默病和其他蛋白质病:种子接种是关键吗?
Amino Acids. 2002;23(1-3):87-93. doi: 10.1007/s00726-001-0113-7.
9
[Neurodegenerative conformational disease and its molecular bases].[神经退行性构象疾病及其分子基础]
Sheng Li Ke Xue Jin Zhan. 2006 Apr;37(2):97-102.
10
How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.绵羊感染如何揭示阿尔茨海默病及其他神经退行性疾病中的朊病毒机制。
Int J Mol Sci. 2021 May 4;22(9):4861. doi: 10.3390/ijms22094861.

引用本文的文献

1
Brain aging and Alzheimer's disease, a perspective from non-human primates.脑衰老与阿尔茨海默病:非人灵长类动物的视角。
Aging (Albany NY). 2024 Oct 29;16(20):13145-13171. doi: 10.18632/aging.206143.
2
Current insights and assumptions on α-synuclein in Lewy body disease.目前对路易体病中α-突触核蛋白的认识和假设。
Acta Neuropathol. 2024 Aug 14;148(1):18. doi: 10.1007/s00401-024-02781-3.
3
α-Synuclein seed amplification technology for Parkinson's disease and related synucleinopathies.α-突触核蛋白种子扩增技术在帕金森病及相关突触核蛋白病中的应用。
Trends Biotechnol. 2024 Jul;42(7):829-841. doi: 10.1016/j.tibtech.2024.01.007. Epub 2024 Feb 23.
4
Uncovering supramolecular chirality codes for the design of tunable biomaterials.揭示用于可调谐生物材料设计的超分子手性编码
Nat Commun. 2024 Jan 26;15(1):788. doi: 10.1038/s41467-024-45019-2.
5
Quantitation of Tissue Amyloid via Fluorescence Spectroscopy Using Controlled Concentrations of Thioflavin-S.利用受控浓度的硫黄素 T 通过荧光光谱法对组织淀粉样蛋白进行定量。
Molecules. 2023 Jun 1;28(11):4483. doi: 10.3390/molecules28114483.
6
Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.阿尔茨海默病是人类大脑自然老化的固有组成部分:综合视角。
Free Neuropathol. 2022 Jul 8;3:17. doi: 10.17879/freeneuropathology-2022-3806. eCollection 2022 Jan.
7
Protein Misfolding and Aggregation in Proteinopathies: Causes, Mechanism and Cellular Response.蛋白质病中的蛋白质错误折叠与聚集:原因、机制及细胞反应
Diseases. 2023 Feb 9;11(1):30. doi: 10.3390/diseases11010030.
8
Aged Cattle Brain Displays Alzheimer's Disease-Like Pathology and Promotes Brain Amyloidosis in a Transgenic Animal Model.老龄牛脑在转基因动物模型中表现出类似阿尔茨海默病的病理学特征并促进脑淀粉样变性。
Front Aging Neurosci. 2022 Jan 31;13:815361. doi: 10.3389/fnagi.2021.815361. eCollection 2021.
9
The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models.衰老相关神经退行性疾病的临床前研究进展:啮齿动物和 hiPSC 衍生模型的视角。
Mol Ther. 2021 Mar 3;29(3):949-972. doi: 10.1016/j.ymthe.2021.01.001. Epub 2021 Jan 9.
10
Identification of Molecular Signatures in Neural Differentiation and Neurological Diseases Using Digital Color-Coded Molecular Barcoding.利用数字彩色编码分子条形码鉴定神经分化和神经疾病中的分子特征。
Stem Cells Int. 2020 Sep 12;2020:8852313. doi: 10.1155/2020/8852313. eCollection 2020.

本文引用的文献

1
Koch's postulates and infectious proteins.科赫法则与传染性蛋白质
Acta Neuropathol. 2006 Jul;112(1):1-4. doi: 10.1007/s00401-006-0072-x. Epub 2006 May 16.
2
Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.脑β-淀粉样血管病的机制:小鼠和细胞模型
Brain Pathol. 2006 Jan;16(1):40-54. doi: 10.1111/j.1750-3639.2006.tb00560.x.
3
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.确定金纳米颗粒被哺乳动物细胞摄取的大小和形状依赖性。
Nano Lett. 2006 Apr;6(4):662-8. doi: 10.1021/nl052396o.
4
Transmissibility of mouse AApoAII amyloid fibrils: inactivation by physical and chemical methods.小鼠载脂蛋白AII淀粉样纤维的传染性:物理和化学方法使其失活
FASEB J. 2006 May;20(7):1012-4. doi: 10.1096/fj.05-4890fje. Epub 2006 Mar 20.
5
Toxic potential of materials at the nanolevel.纳米级材料的潜在毒性。
Science. 2006 Feb 3;311(5761):622-7. doi: 10.1126/science.1114397.
6
Very long term studies of the seeding of beta-amyloidosis in primates.对灵长类动物中β-淀粉样变性播种的长期研究。
J Neural Transm (Vienna). 2006 Sep;113(9):1243-51. doi: 10.1007/s00702-005-0385-2. Epub 2005 Dec 14.
7
Aspects on human amyloid forms and their fibril polypeptides.人类淀粉样蛋白形式及其原纤维多肽的相关方面。
FEBS J. 2005 Dec;272(23):5942-9. doi: 10.1111/j.1742-4658.2005.05024.x.
8
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.正电子发射断层扫描示踪剂匹兹堡化合物-B的结合反映了阿尔茨海默病大脑中β淀粉样蛋白的含量,但在转基因小鼠大脑中并非如此。
J Neurosci. 2005 Nov 16;25(46):10598-606. doi: 10.1523/JNEUROSCI.2990-05.2005.
9
Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR.通过固态核磁共振研究全长α-突触核蛋白原纤维的分子水平二级结构、多态性和动力学。
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15871-6. doi: 10.1073/pnas.0506109102. Epub 2005 Oct 24.
10
Proteasome dysfunction in mammalian aging: steps and factors involved.哺乳动物衰老过程中的蛋白酶体功能障碍:涉及的步骤和因素
Exp Gerontol. 2005 Dec;40(12):931-8. doi: 10.1016/j.exger.2005.09.004. Epub 2005 Oct 24.